Seeley, Marie-Claire 2

Dr Marie-Claire Seeley

Post-Doctoral Fellow, University of Adelaide; CEO, Australian POTS Foundation; Member, Long COVID Collaboration; Facilitator, ADARC Long COVID Consumer and Community Advisory Committee
Dr Marie-Claire Seeley (RN, PhD) is a Post-Doctoral Fellow at the University of Adelaide. With a perspective as a researcher with ‘lived experience,’ she has dedicated her research efforts to exploring postural orthostatic tachycardia syndrome (POTS). Her significant contributions include the establishment of the only Australian patient registry for POTS, which currently holds more than 500 registrants. Dr. Seeley’s research work has elucidated the prevalence of autonomic nervous system disorders in post-acute sequelae of COVID-19 (PASC). Her work has also been instrumental in quantifying reduced quality of life compared to age- and sex-matched populations in PASC and POTS.As the CEO of the Australian POTS Foundation, Dr. Seeley has successful advocated for the adoption of a unique International Disease Code for POTS in Australia. She also serves as a member of the Long COVID Collaboration and facilitator of the ADARC Long COVID Consumer and Community Advisory Committee. Dr. Seeley continues to make significant contributions to the field of autonomic nursing, driving forward research, advocacy, and policy changes to improve outcomes for individuals affected by cardiac dysautonomia.

More from this expert

There is growing interest in a connective tissue condition called Ehlers-Danlos Syndrome

Clinical Articles iconClinical Articles

Marie Claire Seely discusses how primary care clinicians can better recognise, assess and support patients living with POTS and other forms of dysautonomia.

Podcasts iconPodcasts

Upcoming Healthed Webcast

Importance of Early & Effective Treatment of Mild to Moderate Acne

Tuesday 11th November, 7pm - 9pm AEDT

Speaker

Dr Ryan De Cruz

Specialist Dermatologist

We invite you to our next free webcast, where I will discuss the importance of early and effective treatment of mild to moderate acne. Earn up to 4 hours CPD. RACGP & ACRRM accredited.